N-(5-Bromo-3-methylpyridin-2-yl)-N-methylpivalamide

Catalog No. :
ACRAXJ790
CAS No. :
245765-92-8
Molecular Formula :
C12H17BrN2O
Molecular Weight :
285.18

IUPAC Name:N-(5-bromo-3-methylpyridin-2-yl)-N-methylpivalamide

N-(5-Bromo-3-methylpyridin-2-yl)-N-methylpivalamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$114.00Login to see priceInquiryInquiry
1g95%$434.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(5-Bromo-3-methylpyridin-2-yl)-N-methylpivalamide
IUPAC NameN-(5-bromo-3-methylpyridin-2-yl)-N-methylpivalamide
MDL No.MFCD09037448
Molecular FormulaC12H17BrN2O
Molecular Weight285.18
SMILESCC(C)(C)C(N(C1=NC=C(Br)C=C1C)C)=O
InChI KeyMKBZSCNCWLNWFH-UHFFFAOYSA-N
Synonym5-Bromo-3-methyl-2-(N,2,2,2-tetramethylacetamido)pyridine, 95%;N-(5-BROMO-3-METHYLPYRIDIN-2-YL)-N-METHYL-2,2-DIMETHYLPROPANAMIDE;5-Bromo-3-methyl-2-(methyl-pivaloylamino)pyridine;Propanamide, N-(5-bromo-3-methyl-2-pyridinyl)-N,2,2-trimethyl-
CAS No.245765-92-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRAXJ790 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKBCX309 route compound structure diagram
    ACKBCX309245765-66-6 In Stock
  4. Then
  5. ACRAXJ790 route product structure diagram
    ACRAXJ790245765-92-8
Inquiry

2. ACRAXJ790 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRAXJ790 route product structure diagram
    ACRAXJ790245765-92-8
Inquiry

Comments (0)